An update from QSAM Biosciences (QSAM) is now available.
A significant merger has taken place, with QSAM merging with Merger Sub I and subsequently being renamed Telix QSAM, Inc. This corporate shift has led to a complete overhaul of the board, with multiple directors and executive officers, including the CEO and CFO, stepping down. In their place, new directors have taken up their roles, heralding a new era for the company. As a result of these changes, the company’s common stock is set to be delisted from the OTCQB platform following the merger’s regulatory announcements, marking a new chapter in the company’s evolution.
Learn more about QSAM stock on TipRanks’ Stock Analysis page.
